CERENOVUS

CERENOVUS is a global leader in neurovascular care, operating as a business unit within Johnson & Johnson Medical Devices Companies. The company is dedicated to developing innovative therapies and devices for treating hemorrhagic and ischemic strokes, with a focus on improving patient outcomes and reducing long-term disabilities associated with strokes. The company offers a comprehensive range of neurovascular devices, including the Stroke Solutions™ Suite, which features advanced tools for mechanical thrombectomy procedures. This suite includes the CEREBASE™ DA Guide Sheath, the CERENOVUS Large Bore Catheter, and the EMBOTRAP® Revascularization Device. Additionally, CERENOVUS provides the TRUFILL™ n-BCA Liquid Embolic System, designed for treating cerebral arteriovenous malformations. CERENOVUS invests in research to enhance the understanding of blood clots and collaborates with institutions to improve device design. Its products are utilized by healthcare professionals in hospitals and medical centers worldwide, supporting minimally invasive procedures that enhance patient recovery.

• Employees 180
• Founded 2017